Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial

IMPORTANCE: Exenatide, a glucagon-like peptide 1 agonist used in type 2 diabetes, was recently found to have beneficial effects on motor function in a randomized, placebo-controlled trial in Parkinson disease (PD). Accumulating evidence suggests that impaired brain insulin and protein kinase B (Akt)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Neurol
Главные авторы: Athauda, Dilan, Gulyani, Seema, Karnati, Hanuma kumar, Li, Yazhou, Tweedie, David, Mustapic, Maja, Chawla, Sahil, Chowdhury, Kashfia, Skene, Simon S., Greig, Nigel H., Kapogiannis, Dimitrios, Foltynie, Thomas
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2019
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6459135/
https://ncbi.nlm.nih.gov/pubmed/30640362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.4304
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы